Cigna’s Expanding Dividends and Supportive Legislation Provide Value Investors With a Competitive Edge and Short-Term Growth Opportunities

Bank of America’s Top U.S. Stock Picks for Q1: A Tactical Approach

Bank of America has unveiled its latest selection of high-conviction U.S. stocks for the first quarter, focusing on short-term opportunities rather than long-term holdings. The firm’s strategists have identified nine stocks with a Buy rating and one with an Underperform, each chosen for their potential to benefit from significant market or business catalysts in the coming months. This list is intended as a tactical guide for near-term moves, not as a permanent portfolio.

The backdrop for these recommendations is one of caution. Savita Subramanian, BofA’s U.S. equity strategist, has pointed out that “the S&P 500 is expensive,” making it more challenging to find attractive investments. With most stocks trading at elevated valuations, the focus shifts to identifying specific catalysts that could drive individual names. The US1 list is designed to help investors look beyond overall market pricing and pinpoint companies where upcoming developments could spark price movement.

This quarter’s picks are spread across nine different sectors, reflecting a deliberate effort to diversify. While artificial intelligence remains a prominent theme—Amazon stands out for its AWS division and AI leadership—the bank notes that the drivers behind the selections are varied. The list includes companies from retail, energy, healthcare, and aerospace, highlighting that opportunities may arise in many corners of the market, regardless of the broader economic cycle or regulatory environment.

Evaluating Dividend Stocks: Yield, Growth, and Reliability

For those seeking value, dividends represent more than just periodic payments—they signal management’s confidence and provide a tangible return on investment. When considering the five US1 stocks known for passive income, it’s important to look beyond the headline yield. A thorough evaluation should consider the sustainability of the dividend and the quality of its growth.

Cigna Group stands out with a forward yield of 2.22% and a recent 3.31% increase in its quarterly payout. Over the past three years, its dividend has grown at an average annual rate of 11.49%, demonstrating a strong commitment to returning value to shareholders. This pattern of consistent increases suggests robust underlying cash flow.

American Healthcare REIT offers a more predictable profile, distributing a steady $0.25 per quarter for a current yield of 1.93%. Its three-year dividend growth rate is 10.06%. The main attraction here is the reliability of its payouts, a hallmark of well-managed REITs with stable rental income. However, this consistency comes with a lower yield compared to Cigna, reflecting a trade-off between stability and income.

Absolute Momentum Long-Only Strategy: Backtest Overview

• Entry Criteria: Go long on SPY when the 252-day rate of change is positive and the closing price is above the 200-day simple moving average (SMA).
• Exit Criteria: Close the position if the price falls below the 200-day SMA, after 20 trading days, or if a take-profit (+8%) or stop-loss (−4%) is triggered.
• Backtest Period: Last 2 years

Key Results

• Strategy Return: 2.79%
• Annualized Return: 1.43%
• Maximum Drawdown: 2.75%
• Profit-Loss Ratio: 1.46

Trade Statistics

• Total Trades: 169
• Winning Trades: 2
• Losing Trades: 1
• Win Rate: 1.18%
• Average Holding Period: 0.21 days
• Max Consecutive Losses: 1
• Average Win Return: 2.13%
• Average Loss Return: 1.46%
• Largest Single Gain: 2.47%
• Largest Single Loss: 1.46%

One crucial takeaway for investors is that a high yield alone can be misleading. Elevated yields may indicate underlying financial stress, with companies struggling to maintain their payouts. It’s essential to examine the payout ratio—the proportion of earnings or free cash flow distributed as dividends—to ensure it’s at a sustainable level. Firms distributing 90% of their cash flow are more exposed to downturns, while those with a 60% payout have a greater buffer. This approach requires looking past surface numbers to assess true financial health.

Assessing Long-Term Value: Competitive Advantages and Financial Strength

While the US1 list offers a tactical perspective for the quarter, value investors must dig deeper to determine whether these companies have the enduring strengths needed for long-term growth. The real challenge is to identify businesses with lasting competitive advantages and solid financials that can compound value over many years.

Consider Amazon as an example. BofA’s thesis highlights the momentum in AWS and its leadership in artificial intelligence. However, a value-oriented analysis requires examining the durability of AWS’s competitive edge. Does its scale and network effect create a sustainable cost advantage? While the bank’s price target reflects optimism, Amazon’s 2.9% gain over the past year suggests much of this positive outlook may already be reflected in the stock price. Investors must decide if there’s enough margin of safety relative to Amazon’s long-term earnings potential.

Merck is another case in point. The bank points to its “attractive valuation” as a reason for inclusion. While a low price-to-earnings ratio can signal opportunity, it’s important to consider the strength of Merck’s drug pipeline and the staying power of its blockbuster products. Without a robust pipeline, even a cheap stock can be risky if key drugs are nearing patent expiration. Investors must weigh the apparent bargain against the uncertainties of pharmaceutical development.

Across all these picks, the same discipline applies. Analyst price targets are merely educated guesses. Investors should compare these targets to the company’s historical earnings and balance sheet strength. A resilient balance sheet can help weather downturns and support future growth, while a track record of steady earnings demonstrates management’s ability to deliver results. These are the qualities that support long-term value creation.

Ultimately, short-term catalysts are just noise. The real advantage for value investors comes from identifying businesses with strong, defensible moats and buying them at prices that offer a margin of safety. While the US1 list highlights companies with potential near-term drivers, the best investment decisions are made by focusing on the long-term fundamentals.

Key Catalysts, Risks, and Monitoring Points

The US1 list serves as a guide to upcoming catalysts, but value investors must track which events actually occur and whether they lead to meaningful business improvements. The main risk, as BofA notes, is the overall market’s high valuation. Even strong companies may see limited upside if market multiples contract, muting the impact of positive developments.

For the dividend-oriented selections, let’s look at some specific triggers. For Cigna (CI-0.67%), legislative changes are cited as a possible catalyst. Investors should watch for concrete policy announcements, especially those affecting healthcare costs or insurance regulations, as these could alter the company’s operating environment. However, there’s always the risk that legislation is delayed, diluted, or introduces new costs.

Dollar General, on the other hand, could benefit from “higher-than-expected tax refunds in F1Q26,” according to BofA. This seasonal factor may boost consumer spending, but the real test will be the company’s first-quarter earnings report. Investors should look for evidence that increased refunds are translating into higher sales and improved margins. Long-term value, however, will depend on the company’s ability to optimize operations and manage inventory, not just on temporary boosts.

In the end, quarterly earnings are the ultimate benchmark. For all these companies, value investors should focus on the stability of core profits, monitoring margins for signs of cost pressures or competitive threats. Debt levels and capital allocation decisions—such as reducing leverage or investing in growth—are also critical. Strategic initiatives, from Amazon’s AI expansion to Boeing’s production improvements, must be reflected in financial results. Without execution, catalysts remain only potential.